DIRECTRX EXCHANGE Trademark
Trademark Overview
On Friday, December 3, 2021, a trademark application was filed for DIRECTRX EXCHANGE with the United States Patent and Trademark Office. The USPTO has given the DIRECTRX EXCHANGE trademark a serial number of 97156036. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, April 5, 2023. This trademark is owned by Direct Rx Exchange, LLC. The DIRECTRX EXCHANGE trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Providing a website for connecting sellers with buyers; Providing a website used to place on-line commercial orders in the field of medicine
Providing a website featuring technology that enables users to directly connect patients to FDA approved manufacturers to supply directly to the patient as they chose for shipment to them; Providing a website featuring technology that enables users to to connect with doctors who prescribe and dispense via the exchange allowing FDA approved manufacturers to supply directly to the patient as they chose for shipment to them
General Information
| Serial Number | 97156036 |
| Word Mark | DIRECTRX EXCHANGE |
| Filing Date | Friday, December 3, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, April 5, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the exchange & tablet icon on the left in blue and green and words DirectRx Exchange towards the right. Direct was written in green, Rx was written in blue and Exchange was written in green. |
| Pseudo Mark | DIRECT RX EXCHANGE |
| Indication of Colors claimed | The color(s) blue and green is/are claimed as a feature of the mark. |
| Goods and Services | Providing a website for connecting sellers with buyers; Providing a website used to place on-line commercial orders in the field of medicine |
| Goods and Services | Providing a website featuring technology that enables users to directly connect patients to FDA approved manufacturers to supply directly to the patient as they chose for shipment to them; Providing a website featuring technology that enables users to to connect with doctors who prescribe and dispense via the exchange allowing FDA approved manufacturers to supply directly to the patient as they chose for shipment to them |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 7, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 7, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Direct Rx Exchange, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Winnetka, IL 60093 |
Trademark Events
| Event Date | Event Description |
| Wednesday, April 5, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, April 5, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, April 5, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, September 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 21, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 21, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 13, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, December 8, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, December 7, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 7, 2021 | NEW APPLICATION ENTERED |
